Investigations on anti-IGF-1R therapy response in a colorectal cancer cell line panel

<p>Therapies targeting the type 1 insulin like growth factor receptor (IGF-1R) have so far failed to show significant benefit for colorectal cancer (CRC) patients in large clinical trials, emphasising the importance of identifying biomarkers for therapy response and developing rational combina...

Full description

Bibliographic Details
Main Author: Puschhof, J
Other Authors: Bodmer, W
Format: Thesis
Language:English
Published: 2016
Subjects: